# Faeth Therapeutics (FTH): Phase 2 Data, a 42.5% Drop

> Source: IndicatorStack, https://indicatorstack.com/catalysts/fth-2026-11-09-data. Updated Nov 19, 2026, 4:32 AM ET. Prices are indicative. General market information, not a recommendation to buy or sell any security.

Faeth Therapeutics (FTH) released positive preliminary Phase 2 topline results from the PIK-201 at 7:00 AM ET on Monday, November 9, and the stock went from Friday’s $22.05 close to as low as $10.45. It finished the session −42.5% at $12.68 on 10.6 times its 20-day average volume. Here is how it traded, turn by turn, and how LiveChart’s stack read each one.

Catalyst Reaction by IndicatorStack, published Nov 19, 2026, 4:02 AM ET. NASDAQ: FTH, Biotechnology. All times ET.

## The numbers

- −42.5% Monday’s close ($22.05 to $12.68, low $10.45)
- 10.6× its 20-day average volume (4.1M shares on the day)
- 7:00 AM the catalyst crossed, ET (Monday, before the open)
- 18.5M float, shares (22% of the float traded on Monday)

## How the stack read it, checkpoint by checkpoint

| Checkpoint | When | Price | 5m stack bias | Compass |
| --- | --- | --- | --- | --- |
| Before | Fri close | $21.98 | Bullish, firm | 15m and 1h up |
| Into the open | Mon 9:30 AM | $16.00 | Bearish, strong | 15m and 1h down |
| 30 minutes in | Mon 10:00 AM | $12.35 | Bearish, strong | 15m and 1h down |
| At the close | Mon 4:00 PM | $12.68 | Neutral | 15m and 1h down |
| Tuesday’s close | Tue 4:00 PM | $12.85 | Bullish, strong | 15m and 1h split |
| Wednesday’s close | Wed 4:00 PM | $13.36 | Neutral | 15m and 1h split |
| Thursday’s close | Thu 4:00 PM | $10.64 | Bearish, strong | 15m and 1h down |

## Timeline

### Friday, November 6

- 4:00 PM: To Report PIK-201 Phase 2 data and host virtual event on November 9 (Press release, Business Wire)

### Monday, November 9

- 4:45 AM: Premarket high $25.97 (+17.8% from the prior close)
- 7:00 AM: Positive preliminary Phase 2 topline results from the PIK-201 (Press release, Business Wire)
- 7:10 AM: 5-minute stack bias turned bearish (at $17.00)
- 7:19 AM: Current report (Form 8-K) filed (Accepted by the SEC at 7:19:53 AM ET)
- 8:45 AM: Current report (Form 8-K) filed (Accepted by the SEC at 8:45:24 AM ET)
- 9:30 AM: Opened at $16.05 (−27.2% from Friday’s $22.05 close)
- 9:45 AM: Tripwire flagged a trap at the lows (a push through support that failed to hold, at $11.95)
- 12:15 PM: Session low $10.45
- 12:40 PM: Trigger marked a long at $11.59 (Hypothetical, default settings: reached $12.25 at 12:55 PM for +1.1R (structure break, sellers stepped in))
- 12:55 PM: Tripwire flagged a trap at the highs (a push through resistance that failed to hold, at $12.25)
- 1:00 PM: 5-minute stack bias went neutral (at $12.05, its inputs no longer agreeing)
- 1:20 PM: 5-minute stack bias turned bullish (at $12.07)
- 3:45 PM: 5-minute stack bias went neutral (at $12.31, its inputs no longer agreeing)
- 4:00 PM: Closed at $12.68, −42.5% on the day (4.1M shares, 10.6× its 20-day average)

### Tuesday, November 10

- 9:30 AM: Opened at $12.64 (−0.3% from Monday’s $12.68 close)
- 10:10 AM: Trigger marked a short at $12.67 (Hypothetical, default settings: reached $12.08 at 11:25 AM for +1.1R (lower-wick rejection))
- 11:05 AM: 5-minute stack bias turned bearish (at $12.25)
- 11:45 AM: Session low $11.80
- 1:35 PM: 5-minute stack bias went neutral (at $12.48, its inputs no longer agreeing)
- 2:20 PM: Trigger marked a short at $12.06 (Hypothetical, default settings: closed at $12.66 at 2:35 PM for −2.3R (stop))
- 2:30 PM: 5-minute stack bias turned bearish (at $12.24)
- 2:45 PM: 5-minute stack bias went neutral (at $12.80, its inputs no longer agreeing)
- 2:55 PM: 5-minute stack bias turned bullish (at $12.72)
- 4:00 PM: Closed at $12.92, +1.9% on the day (1.4M shares, 2.4× its 20-day average)

### Wednesday, November 11

- 7:30 AM: To participate in upcoming November investor conferences (Press release, Business Wire)
- 9:30 AM: Session low $12.92
- 9:30 AM: Opened at $13.01 (+0.7% from Tuesday’s $12.92 close)
- 9:55 AM: Session high $14.82
- 12:00 PM: 5-minute stack bias went neutral (at $14.02, its inputs no longer agreeing)
- 1:10 PM: 5-minute stack bias turned bearish (at $13.86)
- 1:30 PM: 5-minute stack bias went neutral (at $14.25, its inputs no longer agreeing)
- 1:45 PM: 5-minute stack bias turned bullish (at $14.42)
- 2:05 PM: 5-minute stack bias went neutral (at $13.96, its inputs no longer agreeing)
- 4:00 PM: Closed at $13.35, +3.3% on the day (1.4M shares, 2.2× its 20-day average)

### Thursday, November 12

- 9:30 AM: Opened at $13.17 (−1.3% from Wednesday’s $13.35 close)
- 10:00 AM: Trigger marked a short at $12.22 (Hypothetical, default settings: reached $11.69 at 10:15 AM for +1.2R (volume flow turned up))
- 10:05 AM: 5-minute stack bias turned bearish (at $11.71)
- 3:55 PM: Session low $10.50
- 4:00 PM: Closed at $10.65, −20.2% on the day (767K shares, 1.1× its 20-day average)

## Before the catalyst (Friday, November 6)

Faeth Therapeutics closed Friday at $22.05. The 5-minute stack bias was bullish (firm), since Thursday 1:35 PM: over VWAP 21.08 and a rising SMA, momentum up and trend strength with the buyers. Compass read “15m and 1h up” (15m ↑ 1h ↑ 2h ↑ 4h ↗ D ↘). Undertow: buying drying up, price higher, flow lower. Tripwire: Longs: Avoid, blocked by resistance at 22.03. Its Next row read “Buying drying up near 21.90, giveback risk rising”.

Over the year before, it had traded between $7.45 and $42.14. The week before, on Thursday, November 5, the company had announced inducement Grants Under Nasdaq listing Rule 5635(c)(4) at 4:05 PM ET.

## The Phase 2 data and a 42.5% drop (Monday, November 9)

The release crossed at 7:00 AM ET, with the company’s Form 8-K accepted by the SEC at 7:19 AM. It opened at $16.05, −27.2%, and the regular session ranged from $10.45 to $16.64 before closing at $12.68. It did this on a day SPY rose 2.4% and XBI, the biotechnology ETF, rose 3.1%.

Into the open the stack read it as bearish (strong) with 2 of 2 higher timeframes down, and Undertow read “selling drying up”. Thirty minutes in, the picture had changed: price was below VWAP at $12.59 and the Next row read “Stretched below the averages, bounce area near 13.54”. By the close the 5-minute bias was neutral, while Compass still read “15m and 1h down”: the day’s trend on the 5-minute chart had turned while the higher timeframes it is measured against had not.

## The session after (Tuesday, November 10)

It opened at $12.64 (−0.3%) and traded from $11.80 to $13.93, closing at $12.92, +1.9% on 1.4M shares, still 2.4 times its 20-day average. The 5-minute stack bias was bullish (strong), since 2:55 PM: over VWAP 12.66 and a rising SMA, momentum up, net buying and trend strength with the buyers. Compass read “15m and 1h split” (15m ↗ 1h ↓ 2h ↓ 4h ↘ D ↘). Undertow: buyers in control, real size behind the push. Tripwire: Longs: Clean, nothing major in the way.

## The session after (Wednesday, November 11)

It opened at $13.01 (+0.7%) and traded from $12.92 to $14.82, closing at $13.35, +3.3% on 1.4M shares, still 2.2 times its 20-day average. The 5-minute stack bias was neutral, its inputs disagreeing. Compass read “15m and 1h split” (15m ↗ 1h ↓ 2h ↓ 4h ↓ D ↘). Undertow: volume surge, sellers hitting the bid. Tripwire: Shorts: Clean, nothing major in the way.

## The session after (Thursday, November 12)

It opened at $13.17 (−1.3%) and traded from $10.50 to $13.17, closing at $10.65, −20.2% on 767K shares, still 1.1 times its 20-day average. The 5-minute stack bias was bearish (strong), since 10:05 AM: under VWAP 11.29 and a falling SMA, momentum down, net selling and trend strength with the sellers. Compass read “15m and 1h down” (15m ↓ 1h ↓ 2h ↓ 4h ↓ D ↓). Undertow: volume surge, sellers hitting the bid. Tripwire: Shorts: Clean, nothing major in the way.

After hours it last traded at $10.97, with Undertow reading “sellers in control”.

## Supply

|  |  |  |
| --- | --- | --- |
| Shares outstanding | 25.8M | as reported to the SEC |
| Float | 18.5M | 72% of shares outstanding |
| Reverse splits on record | 1 | 1-for-20 reverse split, June 17, 2025 |
| Last insider purchase | July 1, 2026 | 600 shares at $24.22 by STEPHENSON BRIAN C (Chief Financial Officer) |
| Last insider sale | June 1, 2026 | 25K shares at $20.00 |

## Sources

- Wed Nov 11, 7:30 AM ET, Press release: To participate in upcoming November investor conferences (Business Wire) https://www.businesswire.com/news/home/20261111779875/en/Faeth-Therapeutics-to-Participate-in-Upcoming-November-Investor-Conferences/
- Mon Nov 9, 8:45 AM ET, SEC filing: Current report (Form 8-K) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/1829802/000119312526452755/d19560d8k.htm
- Mon Nov 9, 7:19 AM ET, SEC filing: Current report (Form 8-K) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/1829802/000119312526452643/d199028d8k.htm
- Mon Nov 9, 7:00 AM ET, Press release: Positive preliminary Phase 2 topline results from the PIK-201 (Business Wire) https://www.businesswire.com/news/home/20261109063698/en/Faeth-Reports-Positive-Preliminary-Phase-2-Topline-Results-from-the-PIK-201-Trial-Evaluating-PIKTOR-in-Combination-with-Paclitaxel-in-Patients-with-Advanced-Endometrial-Cancer/
- Fri Nov 6, 4:00 PM ET, Press release: To Report PIK-201 Phase 2 data and host virtual event on November 9 (Business Wire) https://www.businesswire.com/news/home/20261106335577/en/Faeth-to-Report-PIK-201-Phase-2-Data-and-Host-Virtual-Event-on-November-9-2026/
- Tue Nov 3, 8:14 AM ET, SEC filing: Current report (Form 8-K) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/1829802/000119312526444410/d144290dex991.htm
- Tue Nov 3, 8:10 AM ET, SEC filing: Quarterly report (Form 10-Q) (SEC EDGAR) https://www.sec.gov/Archives/edgar/data/1829802/000119312526444376/snse-20260930.htm

## Questions

### Why did FTH stock go down on November 9?

Faeth Therapeutics (FTH) released positive preliminary Phase 2 topline results from the PIK-201 at 7:00 AM ET on Monday, November 9, and the stock went from Friday’s $22.05 close to as low as $10.45. It finished the session −42.5% at $12.68 on 10.6 times its 20-day average volume. The reaction describes the sequence and infers no cause.

### What did Faeth Therapeutics announce on November 9, 2026?

Faeth Therapeutics (FTH) released positive preliminary Phase 2 topline results from the PIK-201 at 7:00 AM ET on Monday, November 9. The company’s release and its Form 8-K are linked in the sources on this page.

### How did FTH stock trade on November 9?

FTH opened at $16.05, −27.2% from the prior close of $22.05, traded between $10.45 and $16.64 in the regular session and closed at $12.68, −42.5%, on 4.1M shares.

### How did LiveChart’s stack read FTH at the close on November 9?

At the 4:00 PM ET close the 5-minute stack bias on FTH was neutral, Compass read “15m and 1h down” and Undertow read “volume surge”. Each turn of the read is on this page’s timeline.

### What does LiveChart’s stack read on FTH now?

The read on this page is fixed at each moment it describes. LiveChart reads FTH on every bar as it trades: open it on LiveChart for the current stack bias, levels and every layer.

Chart: https://indicatorstack.com/chart/FTH. FTH catalyst history: https://indicatorstack.com/catalysts/stock/FTH

Each reaction describes what happened and when, infers no cause and takes no view on what comes next. Past reactions don’t predict future ones.

---

IndicatorStack: on-chart analysis for active traders. LiveChart (https://indicatorstack.com/chart) reads every bar of any US-listed ticker into one held stack bias, the levels to watch and Compass, free. Site guide: https://indicatorstack.com/llms.txt. Today's digest: https://indicatorstack.com/llms-full.txt. Risk Disclosure: https://indicatorstack.com/risk
